My NCBI | Sign In
RSS Settings
  • Search: Hollander PA[au]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 15

    1.

    Safety and efficacy of inhaled human insulin (exubera) during discontinuation and readministration of therapy in adults with type 2 diabetes: a 3-year randomized controlled trial.

    Rosenstock J, Cefalu WT, Hollander PA, Klioze SS, Reis J, Duggan WT.

    Diabetes Technol Ther. 2009 Nov;11(11):697-705.PMID: 19905885 [PubMed - in process]Related articles

    2.

    Safety and efficacy of inhaled human insulin (Exubera) during discontinuation and readministration of therapy in adults with type 1 diabetes: A 3-year randomized controlled trial.

    Skyler JS, Hollander PA, Jovanovic L, Klioze S, Krasner A, Riese RJ, Reis J, Schwartz P, Duggan W; Inhaled Human Insulin Type 1 Diabetes Study Group.

    Diabetes Res Clin Pract. 2008 Nov;82(2):238-46. Epub 2008 Sep 27.PMID: 18824271 [PubMed - indexed for MEDLINE]Related articles

    3.

    Two-year pulmonary safety and efficacy of inhaled human insulin (Exubera) in adult patients with type 2 diabetes.

    Rosenstock J, Cefalu WT, Hollander PA, Belanger A, Eliaschewitz FG, Gross JL, Klioze SS, St Aubin LB, Foyt H, Ogawa M, Duggan WT.

    Diabetes Care. 2008 Sep;31(9):1723-8. Epub 2008 Jun 5.PMID: 18535196 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Body weight changes associated with insulin therapy: a retrospective pooled analysis of inhaled human insulin (Exubera) versus subcutaneous insulin in five controlled Phase III trials.

    Hollander PA, Krasner A, Klioze S, Schwartz P, Duggan W.

    Diabetes Care. 2007 Oct;30(10):2508-10. Epub 2007 May 29. No abstract available. PMID: 17536080 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Evolution of a pulmonary insulin delivery system (Exubera) for patients with diabetes.

    Hollander PA.

    MedGenMed. 2007 Mar 5;9(1):45. Review.PMID: 17435648 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Basal insulin or premix analogue therapy in type 2 diabetes patients.

    Raskin PR, Hollander PA, Lewin A, Gabbay RA, Bode B, Garber AJ; on behalf of the INITIATE Study Group.

    Eur J Intern Med. 2007 Jan;18(1):56-62.PMID: 17223044 [PubMed - in process]Related articles

    7.

    Effectiveness of diabetes resource nurse case management and physician profiling in a fee-for-service setting: a cluster randomized trial.

    Herrin J, Nicewander DA, Hollander PA, Couch CE, Winter FD, Haydar ZR, Warren SS, Ballard DJ.

    Proc (Bayl Univ Med Cent). 2006 Apr;19(2):95-102.PMID: 16609732 [PubMed - as supplied by publisher]Related articlesFree article

    8.

    Efficacy and safety of inhaled insulin (exubera) compared with subcutaneous insulin therapy in patients with type 2 diabetes: results of a 6-month, randomized, comparative trial.

    Hollander PA, Blonde L, Rowe R, Mehta AE, Milburn JL, Hershon KS, Chiasson JL, Levin SR.

    Diabetes Care. 2004 Oct;27(10):2356-62.PMID: 15451900 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Pramlintide as an adjunct to insulin therapy improves long-term glycemic and weight control in patients with type 2 diabetes: a 1-year randomized controlled trial.

    Hollander PA, Levy P, Fineman MS, Maggs DG, Shen LZ, Strobel SA, Weyer C, Kolterman OG.

    Diabetes Care. 2003 Mar;26(3):784-90.PMID: 12610038 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Orlistat: A Viewpoint by Priscilla A. Hollander.

    Hollander PA.

    Drugs. 2001;61(14):2120-2121. No abstract available. PMID: 11735641 [PubMed - as supplied by publisher]Related articles

    11.

    Importance of early insulin secretion: comparison of nateglinide and glyburide in previously diet-treated patients with type 2 diabetes.

    Hollander PA, Schwartz SL, Gatlin MR, Haas SJ, Zheng H, Foley JE, Dunning BE.

    Diabetes Care. 2001 Jun;24(6):983-8.PMID: 11375357 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Current trends in treating type 2 diabetes.

    Hollander PA.

    Postgrad Med. 2000 May 15;107(6 Suppl Key):4-10. Review.PMID: 19667504 [PubMed - indexed for MEDLINE]Related articles

    13.

    Physical performance in persons with spinal cord injuries after discharge from rehabilitation.

    Dallmeijer AJ, van der Woude LH, Hollander PA, Angenot EL.

    Med Sci Sports Exerc. 1999 Aug;31(8):1111-7.PMID: 10449012 [PubMed - indexed for MEDLINE]Related articles

    14.

    Role of orlistat in the treatment of obese patients with type 2 diabetes. A 1-year randomized double-blind study.

    Hollander PA, Elbein SC, Hirsch IB, Kelley D, McGill J, Taylor T, Weiss SR, Crockett SE, Kaplan RA, Comstock J, Lucas CP, Lodewick PA, Canovatchel W, Chung J, Hauptman J.

    Diabetes Care. 1998 Aug;21(8):1288-94.PMID: 9702435 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    New oral agents for type II diabetes. Taking a more aggressive approach to therapy.

    Hollander PA.

    Postgrad Med. 1995 Dec;98(6):110-1, 115-6, 119-21, passim.PMID: 7501573 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    3 free full-text articles in PubMed Central

    Find related data

    Search details

    » See more...

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    » See more...